Ratings by Craig-Hallum (Adam Vogel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2026 | Aclaris Therapeutis | ACRS | New Coverage | Buy (N/A) |
3.43 (3.06) |
-10.79% | Details | |
| 1/7/2026 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Design Therapeutics Inc | DSGN | New Coverage | Buy (N/A) |
8.94 (10.05) |
12.42% | Details | |
| 11/3/2025 | Apogee Therapeutics Inc | APGE | New Coverage | Buy (N/A) |
56.59 (73.05) |
29.09% | Details | |
| 9/5/2025 | Immunome Inc. | IMNM | New Coverage | Buy (N/A) |
9.80 (21.04) |
114.69% | Details |
